Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin Induced Thrombocytopenia (HIT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00673439
What this trial is testing

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
University of Louisville 3
Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5
Large-scale testing (Phase 3)Ended earlyNCT01598168
What this trial is testing

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
McMaster University 22
Not applicableStudy completedNCT00456326
What this trial is testing

Heparin-Induced Thrombocytopenia Registry

Who this might be right for
Heparin-Induced Thrombocytopenia
Brigham and Women's Hospital 242
Not applicableStudy completedNCT01654848
What this trial is testing

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients

Who this might be right for
Heparin-induced ThrombocytopeniaLiver Transplantation
CHIR-Net 39
Large-scale testing (Phase 3)Study completedNCT00329433
What this trial is testing

Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery

Who this might be right for
Deep Venous Thrombosis
Washington University School of Medicine 120
Post-approval studies (Phase 4)Ended earlyNCT00798525
What this trial is testing

Argatroban Versus Lepirudin in Critically Ill Patients

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Heinrich-Heine University, Duesseldorf 70
Not applicableStudy completedNCT01304238
What this trial is testing

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

Who this might be right for
Acute HIT II (Heparin-induced Thrombocytopenia Type II)
GlaxoSmithKline 195
Post-approval studies (Phase 4)UnknownNCT00196417
What this trial is testing

The HIT-TRAP Trial

Who this might be right for
Heparin-Induced Thrombocytopenia
University Medicine Greifswald 600
Not applicableUnknownNCT06066762
What this trial is testing

Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.

Who this might be right for
Heparin-induced Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 200
Not applicableStudy completedNCT03979625
What this trial is testing

Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation

Who this might be right for
Heparin-induced Thrombocytopenia
Central Hospital, Nancy, France 39
Post-approval studies (Phase 4)Study completedNCT00913133
What this trial is testing

Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis

Who this might be right for
Thrombosis
Canyon Pharmaceuticals, Inc. 516
Not applicableStudy completedNCT04842760
What this trial is testing

PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer

Who this might be right for
Platelet DisorderHeparin-induced ThrombocytopeniaPlatelet Activation+1 more
Centre Hospitalier Universitaire, Amiens 31
Not applicableUnknownNCT05586854
What this trial is testing

Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia

Who this might be right for
Dialysis; ComplicationsHeparin-induced ThrombocytopeniaChronic Renal Failure
GCS Ramsay Santé pour l'Enseignement et la Recherche 20
Post-approval studies (Phase 4)WithdrawnNCT00759083
What this trial is testing

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Who this might be right for
Heparin-Induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis Syndrome
The Medicines Company
Large-scale testing (Phase 3)Ended earlyNCT03809481
What this trial is testing

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Who this might be right for
Heparin-induced Thrombocytopenia
Aspen Global Incorporated 7
Not applicableUnknownNCT04782843
What this trial is testing

Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.

Who this might be right for
Heparin-induced Thrombocytopenia
Centre Hospitalier Universitaire de Besancon 124
Not applicableLooking for participantsNCT06033300
What this trial is testing

Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-induced ThrombocytopeniaHITPlatelet Activation+5 more
Centre Hospitalier Universitaire, Amiens 200
Not applicableUnknownNCT04751357
What this trial is testing

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

Who this might be right for
Heparin-induced Thrombocytopenia
Medical University of Vienna 21
Post-approval studies (Phase 4)Ended earlyNCT00787332
What this trial is testing

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Who this might be right for
Suspected Heparin-Induced Thrombocytopenia
Canyon Pharmaceuticals, Inc. 16
Next Page